Compile Data Set for Download or QSAR
maximum 50k data
Found 86 with Last Name = 'rayner' and Initial = 'jw'
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116590(CHEMBL325486 | N-(9-Methanesulfonyl-9H-carbazol-3-...)
Affinity DataIC50:  1nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116610(CHEMBL119743 | N-(9-Isopropyl-9H-carbazol-3-yl)-3-...)
Affinity DataIC50:  1nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116619(CHEMBL117563 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116602(CHEMBL419951 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116600(CHEMBL325475 | N-(9-Ethyl-9H-carbazol-3-yl)-3-pyri...)
Affinity DataIC50:  2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116605(CHEMBL432628 | Morpholine-4-carboxylic acid (6-flu...)
Affinity DataIC50:  3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116592(CHEMBL325226 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116617(CHEMBL116210 | N-(9-Acetyl-9H-carbazol-3-yl)-3-pyr...)
Affinity DataIC50:  3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116592(CHEMBL325226 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  6nMAssay Description:Compound was evaluated for functional antagonism of Neuropeptide Y receptor Y5 activity in cellular Ca fluxMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116600(CHEMBL325475 | N-(9-Ethyl-9H-carbazol-3-yl)-3-pyri...)
Affinity DataIC50:  7nMAssay Description:Binding affinity against rat Neuropeptide Y receptor Y5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116597(CHEMBL119247 | Morpholine-4-carboxylic acid (9-eth...)
Affinity DataIC50:  7nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116608(CHEMBL117922 | N-(9-Dimethylsulfamoyl-9H-carbazol-...)
Affinity DataIC50:  8nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116600(CHEMBL325475 | N-(9-Ethyl-9H-carbazol-3-yl)-3-pyri...)
Affinity DataIC50:  11nMAssay Description:Compound was evaluated in vitro for human Neuropeptide Y receptor Y5 functional antagonism (reporter gene assay)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116607(CHEMBL325639 | Morpholine-4-carboxylic acid (2,4-d...)
Affinity DataIC50:  12nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116603(CHEMBL443809 | Morpholine-4-carboxylic acid (9-met...)
Affinity DataIC50:  15nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116612(CHEMBL118973 | N-(9-Methyl-9H-carbazol-3-yl)-3-pyr...)
Affinity DataIC50:  33nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116592(CHEMBL325226 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  37nMAssay Description:The compound was evaluated in vitro for: human Neuropeptide Y receptor Y5 functional antagonismMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116618(CHEMBL324028 | Morpholine-4-carboxylic acid [9-(te...)
Affinity DataIC50:  40nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116609(CHEMBL119426 | Morpholine-4-carboxylic acid [9-(2,...)
Affinity DataIC50:  78nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116613(CHEMBL325666 | N-(9H-Carbazol-3-yl)-3-pyridin-4-yl...)
Affinity DataIC50:  230nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116594(CHEMBL118098 | Morpholine-4-carboxylic acid (4-eth...)
Affinity DataIC50:  270nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116604(CHEMBL327151 | N-(4-Benzoyl-phenyl)-3-pyridin-4-yl...)
Affinity DataIC50:  300nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116598(CHEMBL331019 | N-(4-Benzoyl-phenyl)-2-(pyridin-4-y...)
Affinity DataIC50:  350nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116615(CHEMBL324366 | Morpholine-4-carboxylic acid (9-dim...)
Affinity DataIC50:  350nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116599(CHEMBL119726 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  390nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116616(CHEMBL117684 | N-(9-Ethyl-9H-carbazol-1-yl)-3-pyri...)
Affinity DataIC50:  440nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116606(9-Ethyl-9H-carbazole-3-carboxylic acid (2-pyridin-...)
Affinity DataIC50:  700nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116611(CHEMBL117469 | Morpholine-4-carboxylic acid (9-iso...)
Affinity DataIC50:  710nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116601(CHEMBL118710 | Morpholine-4-carboxylic acid (4,9-d...)
Affinity DataIC50:  770nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116593(CHEMBL115690 | N-(9-Ethyl-9H-carbazol-2-yl)-3-pyri...)
Affinity DataIC50:  800nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116595(CHEMBL435384 | N-(9-Ethyl-9H-carbazol-3-yl)-N-meth...)
Affinity DataIC50:  2.20E+3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116591(2-(9-Ethyl-9H-carbazol-3-yl)-N-pyridin-4-ylmethyl-...)
Affinity DataIC50:  2.25E+3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116614(CHEMBL117626 | N-(9-Ethyl-9H-carbazol-3-ylmethyl)-...)
Affinity DataIC50:  3.40E+3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50116596(CHEMBL331581 | N-(9-Ethyl-9H-carbazol-4-yl)-3-pyri...)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165025(6-[3-Isopropoxy-5-(2-pyridin-3-yl-ethoxy)-benzoyla...)
Affinity DataEC50:  1.26E+3nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165026(6-(2-Benzyloxy-5-methylsulfanyl-benzoylamino)-nico...)
Affinity DataEC50:  4.22E+3nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165028(6-[(E)-2-(2-Benzyloxy-5-methylsulfanyl-phenyl)-vin...)
Affinity DataEC50:  3.20E+3nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165027(6-[2-(3,5-Bis-benzyloxy-phenyl)-ethyl]-nicotinic a...)
Affinity DataEC50: >1.00E+4nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165029(6-[3-(2-Cyclopentyl-ethoxy)-5-isopropoxy-benzoylam...)
Affinity DataEC50:  170nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165030(6-(3,5-Bis-benzyloxy-benzoylamino)-nicotinic acid ...)
Affinity DataEC50:  400nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165031(6-({3-isopropoxy-5-[2-(3-thienyl)ethoxy]benzoyl}am...)
Affinity DataEC50:  90nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165032(6-(2-Benzyloxy-5-methylsulfanyl-phenylcarbamoyl)-n...)
Affinity DataEC50: >1.00E+4nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165034(6-[3-Isopropoxy-5-(2-pyridin-4-yl-ethoxy)-benzoyla...)
Affinity DataEC50:  1.78E+3nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165033(6-[2,3-Bis-(2-chloro-benzyloxy)-benzoylamino]-nico...)
Affinity DataEC50: >1.00E+4nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165035(6-[3-(2-Fluoro-benzyloxy)-5-isopropoxy-benzoylamin...)
Affinity DataEC50:  100nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165037(6-(3-Isobutoxy-5-isopropoxy-benzoylamino)-nicotini...)
Affinity DataEC50:  570nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165036(6-(3,5-Bis-benzyloxy-phenylcarbamoyl)-nicotinic ac...)
Affinity DataEC50: >1.00E+4nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165038(6-(3,5-Bis-benzyloxy-benzyloxy)-nicotinic acid | C...)
Affinity DataEC50: >1.00E+4nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165040(6-(3-Isopropoxy-5-phenethyloxy-benzoylamino)-nicot...)
Affinity DataEC50:  130nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHexokinase-4(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50165039(6-[3-(2-Chloro-benzyloxy)-benzoylamino]-nicotinic ...)
Affinity DataEC50:  910nMAssay Description:Potency in Glucokinase activation assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 86 total ) | Next | Last >>
Jump to: